Financials data is unavailable for this security.
View more
Year on year CVS Health Corp grew revenues 10.95% from 322.47bn to 357.78bn while net income improved 93.55% from 4.31bn to 8.34bn.
| Gross margin | 15.21% |
|---|---|
| Net profit margin | 2.34% |
| Operating margin | 3.84% |
| Return on assets | 3.50% |
|---|---|
| Return on equity | 11.28% |
| Return on investment | 5.09% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at CVS Health Corp fell by 4.78bn. However, the company earned 13.43bn from its operations for a Cash Flow Margin of 3.75%. In addition the company generated 2.68bn cash from financing while 20.89bn was spent on investing.
| Cash flow per share | 9.87 |
|---|---|
| Price/Cash flow per share | 6.70 |
| Book value per share | 59.36 |
|---|---|
| Tangible book value per share | -34.20 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.8569 |
|---|---|
| Quick ratio | 0.6293 |
| Total debt/total equity | 0.8058 |
|---|---|
| Total debt/total capital | 0.4457 |
More ▼
Growth rates in USD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 19.85% and 98.50%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Retail (Drugs) industry pay a dividend. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 2.65% |
|---|---|
| Div growth rate (5 year) | 5.68% |
| Payout ratio (TTM) | 37.61% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 99.37 |
More ▼
